NASDAQ:CME CME Group (CME) Stock Forecast, Price & News $205.77 +0.97 (+0.47%) (As of 08/11/2023 08:48 PM ET) Add Compare Share Share Today's Range$204.16▼$206.6350-Day Range$177.74▼$208.3652-Week Range$166.54▼$209.31Volume1.01 million shsAverage Volume1.65 million shsMarket Capitalization$74.03 billionP/E Ratio25.12Dividend Yield2.14%Price Target$211.70 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability CME Group MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside2.9% Upside$211.70 Price TargetShort InterestHealthy1.20% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.26Upright™ Environmental ScoreNews Sentiment0.60Based on 20 Articles This WeekInsider TradingSelling Shares$4.39 M Sold Last QuarterProj. Earnings Growth1.10%From $9.05 to $9.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.34 out of 5 starsFinance Sector419th out of 866 stocksSecurity & Commodity Brokers, Dealers, Exchanges & Services Industry4th out of 8 stocks 1.3 Analyst's Opinion Consensus RatingCME Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $211.70, CME Group has a forecasted upside of 2.9% from its current price of $205.77.Amount of Analyst CoverageCME Group has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.20% of the float of CME Group has been sold short.Short Interest Ratio / Days to CoverCME Group has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CME Group has recently increased by 0.71%, indicating that investor sentiment is decreasing. Previous Next 4.2 Dividend Strength Dividend YieldCME Group pays a meaningful dividend of 2.14%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCME Group has been increasing its dividend for 13 years.Dividend CoverageThe dividend payout ratio of CME Group is 53.72%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, CME Group will have a dividend payout ratio of 48.09% next year. This indicates that CME Group will be able to sustain or increase its dividend. Previous Next 2.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCME Group has received a 24.21% net impact score from Upright. The largest positive contribution comes from its "Distributing knowledge" impact, which is false driven by its "Stock exchanges", "Bond exchange services", and "Derivatives exchange services" products. See details.Environmental SustainabilityThe Environmental Impact score for CME Group is -0.26. Previous Next 2.6 News and Social Media Coverage News SentimentCME Group has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 20 news articles for CME Group this week, compared to 7 articles on an average week.Search Interest21 people have searched for CME on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.MarketBeat FollowsOnly 8 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CME Group insiders have sold 174,273.98% more of their company's stock than they have bought. Specifically, they have bought $2,517.00 in company stock and sold $4,388,993.00 in company stock.Percentage Held by InsidersOnly 0.30% of the stock of CME Group is held by insiders.Percentage Held by Institutions85.98% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for CME Group are expected to grow by 1.10% in the coming year, from $9.05 to $9.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CME Group is 25.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.71.Price to Earnings Ratio vs. SectorThe P/E ratio of CME Group is 25.12, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 84.81.Price to Earnings Growth RatioCME Group has a PEG Ratio of 3.19. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCME Group has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About CME Group (NASDAQ:CME) StockCME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.Read More CME Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CME Stock News HeadlinesAugust 13, 2023 | americanbankingnews.comCME Group Inc. (NASDAQ:CME) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 13, 2023 | americanbankingnews.comSingapore Exchange (OTCMKTS:SPXCY) and CME Group (NASDAQ:CME) Head to Head SurveyAugust 14, 2023 | Behind the Markets (Ad)The Wall Street Journal Calls this the "KING KONG" of New DrugsIt took Lipitor 27 years to reach 114 million prescriptions a year... It took Metformin 28 years to reach 92 million prescriptions a year... And it took Zoloft 33 years to reach 38 million prescriptions a year... But Morgan Stanley predicts one new drug will reach 250 million prescriptions a year by 2030. Get the rest of the story here >>>August 11, 2023 | americanbankingnews.comDaniel R. Glickman Sells 750 Shares of CME Group Inc. (NASDAQ:CME) StockAugust 10, 2023 | americanbankingnews.comHilda Harris Piell Sells 4,477 Shares of CME Group Inc. (NASDAQ:CME) StockAugust 6, 2023 | msn.comHere's the prize money payout for each golfer at the 2023 Freed Group Women's Scottish OpenAugust 5, 2023 | americanbankingnews.comCME Group Inc. (CME) To Go Ex-Dividend on September 7thAugust 3, 2023 | finance.yahoo.comAsset Managers Line Up To File for Ethereum Futures ETFsAugust 14, 2023 | Behind the Markets (Ad)The Wall Street Journal Calls this the "KING KONG" of New DrugsIt took Lipitor 27 years to reach 114 million prescriptions a year... It took Metformin 28 years to reach 92 million prescriptions a year... And it took Zoloft 33 years to reach 38 million prescriptions a year... But Morgan Stanley predicts one new drug will reach 250 million prescriptions a year by 2030. Get the rest of the story here >>>July 28, 2023 | bitcoinist.comCME Group: Ethereum To Outperform Bitcoin After Halving?July 27, 2023 | markets.businessinsider.com6 Analysts Have This to Say About CME GrJuly 27, 2023 | markets.businessinsider.comBank of America Securities Reaffirms Their Sell Rating on CME Group (CME)July 27, 2023 | cnbc.comCME Group CEO Terry Duffy reacts to Fed decision, A.I. and moreJuly 27, 2023 | finance.yahoo.comQ2 2023 CME Group Inc Earnings CallJuly 25, 2023 | finance.yahoo.comThe Hottest Trade in Equity Options Is Spreading to CommoditiesJuly 18, 2023 | finance.yahoo.comCME Group and DTCC to Increase Cross-Margining Opportunities for the Treasury MarketsJuly 13, 2023 | finance.yahoo.com3 Incredible Stocks Trading at Historical DiscountsJuly 13, 2023 | msn.comMorgan Stanley Maintains CME Group Inc - (CME) Equal-Weight RecommendationJuly 13, 2023 | finance.yahoo.comIs CME Group (CME) Stock Outpacing Its Finance Peers This Year?July 6, 2023 | marketwatch.comCME Group Inc. Cl A stock falls Thursday, still outperforms marketJuly 6, 2023 | markets.businessinsider.comBarclays Sticks to Its Buy Rating for CME Group (CME)July 6, 2023 | markets.businessinsider.comCiti Sticks to Its Buy Rating for CME Group (CME)July 6, 2023 | msn.comRosenblatt Maintains CME Group Inc - (CME) Sell RecommendationJune 30, 2023 | bitcoinist.comCME Group To Unveil Ethereum-Bitcoin Ratio Futures, A New Era In Crypto?June 29, 2023 | finance.yahoo.comMicro WTI Crude Oil Futures Surpass 50 Million Contracts Traded, Now Fifth Most Actively Traded Energy Futures ContractJune 28, 2023 | msn.comBarclays Initiates Coverage of CME Group Inc - (CME) with Overweight RecommendationJune 28, 2023 | markets.businessinsider.com5 Analysts Have This to Say About CME GrSee More Headlines Receive CME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CME Company Calendar Ex-Dividend for 6/27 Dividend6/08/2023Dividend Payable6/27/2023Last Earnings7/26/2023Today8/14/2023Ex-Dividend for 9/27 Dividend9/07/2023Dividend Payable9/27/2023Next Earnings (Estimated)10/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Security & commodity brokers, dealers, exchanges & services Sub-IndustrySpecialized Finance SectorFinance Current SymbolNASDAQ:CME CUSIP12572Q10 CIK1156375 Webwww.cmegroup.com Phone(312) 930-1000Fax312-466-4410Employees3,460Year Founded1848Price Target and Rating Average Stock Price Forecast$211.70 High Stock Price Forecast$250.00 Low Stock Price Forecast$173.00 Forecasted Upside/Downside+2.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$8.19 Trailing P/E Ratio25.12 Forward P/E Ratio22.74 P/E Growth3.19Net Income$2.69 billion Net Margins56.88% Pretax Margin74.09% Return on Equity11.30% Return on Assets1.86% Debt Debt-to-Equity Ratio0.12 Current Ratio1.02 Quick Ratio1.02 Sales & Book Value Annual Sales$5.02 billion Price / Sales14.75 Cash Flow$9.09 per share Price / Cash Flow22.64 Book Value$77.33 per share Price / Book2.66Miscellaneous Outstanding Shares359,750,000Free Float358,670,000Market Cap$74.03 billion OptionableOptionable Beta0.43 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Terrence A. Duffy (Age 65)Chairman & CEO Comp: $10.38MMs. Julie Holzrichter (Age 54)Sr. MD & COO Comp: $1.65MMr. Sunil Cutinho (Age 51)Chief Information Officer Comp: $1.64MMr. John William Pietrowicz CPA (Age 59)M.B.A., Special Advisor Comp: $1.89MMs. Lynne Fitzpatrick (Age 44)Chief Financial Officer Mr. Jack Tobin (Age 59)MD & Chief Accounting Officer Mr. John C. Peschier (Age 55)Managing Director of Investor Relations Mr. Jonathan L. MarcusSr. MD & Gen. CounselMs. Anita Liskey (Age 58)Sr. Managing Director of Corp. Marketing & Communications Ms. Hilda Harris Piell (Age 55)Sr. MD & Chief HR Officer More ExecutivesKey CompetitorsIntercontinental ExchangeNYSE:ICENasdaqNASDAQ:NDAQT. Rowe Price GroupNASDAQ:TROWTradeweb MarketsNASDAQ:TWProgressiveNYSE:PGRView All CompetitorsInsiders & InstitutionsBRITISH COLUMBIA INVESTMENT MANAGEMENT CorpBought 273 shares on 8/11/2023Ownership: 0.009%Capital Group Investment Management PTE. LTD.Sold 93 shares on 8/11/2023Ownership: 0.003%Wills Financial Group Inc.Sold 79 shares on 8/11/2023Ownership: 0.001%Huntington National BankSold 85 shares on 8/11/2023Ownership: 0.001%Covestor LtdSold 95 shares on 8/11/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions CME Stock - Frequently Asked Questions Should I buy or sell CME Group stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CME shares. View CME analyst ratings or view top-rated stocks. What is CME Group's stock price forecast for 2023? 10 equities research analysts have issued twelve-month price targets for CME Group's stock. Their CME share price forecasts range from $173.00 to $250.00. On average, they anticipate the company's share price to reach $211.70 in the next year. This suggests a possible upside of 2.9% from the stock's current price. View analysts price targets for CME or view top-rated stocks among Wall Street analysts. How have CME shares performed in 2023? CME Group's stock was trading at $168.16 on January 1st, 2023. Since then, CME stock has increased by 22.4% and is now trading at $205.77. View the best growth stocks for 2023 here. When is CME Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023. View our CME earnings forecast. How were CME Group's earnings last quarter? CME Group Inc. (NASDAQ:CME) announced its earnings results on Wednesday, July, 26th. The financial services provider reported $2.30 EPS for the quarter, topping analysts' consensus estimates of $2.20 by $0.10. The financial services provider had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.34 billion. CME Group had a trailing twelve-month return on equity of 11.30% and a net margin of 56.88%. The business's quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.97 EPS. Read the conference call transcript. How often does CME Group pay dividends? What is the dividend yield for CME Group? CME Group announced a quarterly dividend on Thursday, August 3rd. Stockholders of record on Friday, September 8th will be paid a dividend of $1.10 per share on Wednesday, September 27th. This represents a $4.40 annualized dividend and a dividend yield of 2.14%. The ex-dividend date is Thursday, September 7th. Read our dividend analysis for CME. What ETFs hold CME Group's stock? ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Horizon Kinetics Blockchain Development ETF (BCDF), Tema Monopolies and Oligopolies ETF (TOLL), SmartETFs Dividend Builder ETF (DIVS), TrueShares Low Volatility Equity Income ETF (DIVZ), Capital Link Global Fintech Leaders ETF (KOIN), VanEck Morningstar ESG Moat ETF (MOTE) and Amplify Transformational Data Sharing ETF (BLOK). Is CME Group a good dividend stock? CME Group (NASDAQ:CME) pays an annual dividend of $4.40 per share and currently has a dividend yield of 2.14%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 53.72%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 48.09% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CME. What is Terry Duffy's approval rating as CME Group's CEO? 294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend. What other stocks do shareholders of CME Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC). What is CME Group's stock symbol? CME Group trades on the NASDAQ under the ticker symbol "CME." Who are CME Group's major shareholders? CME Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (152.73%), BlackRock Inc. (6.56%), Capital International Investors (3.89%), Capital World Investors (3.67%), Capital Research Global Investors (2.55%) and Geode Capital Management LLC (2.02%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard. View institutional ownership trends. How do I buy shares of CME Group? Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CME Group's stock price today? One share of CME stock can currently be purchased for approximately $205.77. How much money does CME Group make? CME Group (NASDAQ:CME) has a market capitalization of $74.03 billion and generates $5.02 billion in revenue each year. The financial services provider earns $2.69 billion in net income (profit) each year or $8.19 on an earnings per share basis. How many employees does CME Group have? The company employs 3,460 workers across the globe. How can I contact CME Group? CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The official website for the company is www.cmegroup.com. The financial services provider can be reached via phone at (312) 930-1000, via email at info@cmegroup.com, or via fax at 312-466-4410. This page (NASDAQ:CME) was last updated on 8/14/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.